Use and performance of the evolut FX transcatheter aortic valve system-Reference-Cited by-同舟云学术

Use and performance of the evolut FX transcatheter aortic valve system

Published:2024-04 Issue: Volume: Page:
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Bajwa Tanvir,Attizzani Guilherme F.,Gada Hemal,Chetcuti Stanley J.,Williams Mathew R.,Ahmed Mustafa,Petrossian George A.,Saybolt Matthew D.,Allaqaband Suhail Q.,Merhi William M.,Stoler Robert C.,Bezerra Hiram,Mahoney Paul,Wu Willis,Jumper Robert,Lambrecht Larry,Tang Gilbert H.L.

Funder

Medtronic

Medtronic Inc

Publisher

Elsevier BV

Reference26 articles.

1. 2020 ACC/AHA guideline for the Management of Patients with Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Otto;J Am Coll Cardiol,2021

2. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description;Cribier;Circulation,2002

3. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving system;Berry;Catheter Cardiovasc Interv,2007

4. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system;Manoharan;JACC Cardiovasc Interv,2015

5. Early outcomes with the Evolut PRO repositionable self-expanding transcatheter aortic valve with pericardial wrap;Forrest;JACC Cardiovasc Interv,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Going from Evolut PRO+ to Evolut FX: A step in the right direction;Cardiovascular Revascularization Medicine;2024-05